Corrigendum to "Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool" [Contemporary Clinical Trials. 2016 Jul. 19; 50: 90-97].

a Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA b Department of Medicine, Division of General Internal Medicine, Duke University Medical Center, Durham, NC, USA c Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, USA d Center for Child and Family Policy, Duke University, Durham, NC, USA e Department of Population Health, New York University School of Medicine, New York, NY, USA f National Institute on Drug Abuse, Bethesda, MD, USA g The EMMES Corporation, Rockville, MD, USA h Friends Research Institute, Inc., Baltimore, MD, USA